What You Should Know:
– DrFirst announced the appointment of Laizer Kornwasser as its new Chief Executive Officer, effective July 21, 2025. Kornwasser, a transformative healthcare executive with a proven track record of driving rapid growth, will lead DrFirst as it continues to build on 25 years of leadership in medication management solutions.
– G. Cameron Deemer, who has served as CEO since 2023 and president for 15 years, will transition to supporting the company’s strategic initiatives as vice chairman of the board of directors. This planned succession reinforces DrFirst’s commitment to innovation and sustained growth.
A New Era of Leadership and Expansion
DrFirst annually reaches over 100 million patients through its end-to-end medication management solutions, leveraging integrations and partnerships with electronic systems used by hospitals, medical practices, and pharmacies nationwide.
Kornwasser brings over two decades of healthcare leadership experience spanning pharmacy, telemedicine, chronic care, pharmaceutical companies, and PBMs. Most recently, he served as president of enterprise growth and emerging markets at Teladoc Health. His prior senior executive roles include positions at CareCentrix and Medco Health. Kornwasser holds an MBA from Harvard Business School and has also served as a professor at Yeshiva University’s Sy Syms School of Business.
“What drew me to this company is its consistent ability to identify gaps in medication management and create effective solutions to close those gaps, while maintaining an unwavering commitment to customers and employees,” said Kornwasser. “DrFirst has built something extraordinary—patented AI technologies, the nation’s largest medication management network, and deep integration with virtually every major EHR system. I’m excited to lead this exceptional team as we accelerate our strategy and continue to deliver comprehensive, interoperable solutions.”
